Gruber A - Search Results

1

Pharmacokinetics of mitoxantrone, etoposide and cytosine arabinoside in leukemic cells during treatment of acute myelogenous leukemia--relationship to treatment outcome and bone marrow toxicity.

Gruber A, Liliemark E, Tidefelt U, Paul C, Björkholm M, Peterson C, Liliemark J. Gruber A, et al. Leuk Res. 1995 Oct;19(10):757-61. doi: 10.1016/0145-2126(95)00061-r. Leuk Res. 1995. PMID: 7500654

2

Real-time RT-PCR for the determination of topoisomerase II mRNA level in leukaemic cells.

Zhou R, Frostvik Stolt M, Kronenwett U, Gruber A, Liliemark J, Liliemark E. Zhou R, et al. Among authors: gruber a. Leuk Res. 2002 May;26(5):487-94. doi: 10.1016/s0145-2126(01)00144-8. Leuk Res. 2002. PMID: 11916525

3

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.

Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J. Gruber A, et al. Leuk Res. 2003 Apr;27(4):323-8. doi: 10.1016/s0145-2126(02)00181-9. Leuk Res. 2003. PMID: 12531223 Clinical Trial.

4

Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison.

Björkholm M, Liliemark J, Gahrton G, Grimfors G, Gruber A, Hast R, Juliusson G, Järnmark M, Killander A, Kimby E, et al. Björkholm M, et al. Among authors: gruber a. Eur J Haematol. 1995 Jul;55(1):19-23. doi: 10.1111/j.1600-0609.1995.tb00228.x. Eur J Haematol. 1995. PMID: 7615046 Clinical Trial.

5

A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.

Gruber A, Larsson R, Nygren P, Björkholm M, Peterson C. Gruber A, et al. Leukemia. 1994 Jun;8(6):985-9. Leukemia. 1994. PMID: 7911547

6

In vivo accumulation of etoposide in peripheral leukemic cells in patients treated for acute myeloblastic leukemia; relation to plasma concentrations and protein binding.

Liliemark EK, Liliemark J, Pettersson B, Gruber A, Björkholm M, Peterson C. Liliemark EK, et al. Among authors: gruber a. Leuk Lymphoma. 1993 Jul;10(4-5):323-8. doi: 10.3109/10428199309148555. Leuk Lymphoma. 1993. PMID: 8220130

7

On the interaction between cytosine arabinoside and etoposide in vivo and in vitro.

Liliemark J, Knochenhauer E, Gruber A, Pettersson B, Björkholm M, Peterson C. Liliemark J, et al. Among authors: gruber a. Eur J Haematol. 1993 Jan;50(1):22-5. doi: 10.1111/j.1600-0609.1993.tb00069.x. Eur J Haematol. 1993. PMID: 8436210

8

Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo.

Sundman-Engberg B, Tidefelt U, Gruber A, Paul C. Sundman-Engberg B, et al. Among authors: gruber a. Leuk Res. 1993 Apr;17(4):347-52. doi: 10.1016/0145-2126(93)90022-d. Leuk Res. 1993. PMID: 8487583

9

Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression.

Gruber A, Briese B, Areström I, Vitols S, Björkholm M, Peterson C. Gruber A, et al. Leuk Res. 1993 Apr;17(4):353-8. doi: 10.1016/0145-2126(93)90023-e. Leuk Res. 1993. PMID: 8487584

10

Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.

Gruber A, Areström I, Albertioni F, Björkholm M, Peterson C, Vitols S. Gruber A, et al. Leuk Lymphoma. 1995 Aug;18(5-6):435-42. doi: 10.3109/10428199509059642. Leuk Lymphoma. 1995. PMID: 8528050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,280 results

Search Page

Filters